lipoxin a4 and Alzheimer Disease

lipoxin a4 has been researched along with Alzheimer Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Assunção, N; Bozza, FA; Canetti, CA; Castro-Faria-Neto, HC; Chauvet, MG; Coutinho, G; Drummond, C; Ferreira, ST; Isaac, AR; Karmirian, K; Ledur, PF; Leo, LM; Lourenco, MV; Mattos, P; Moraes, CA; Ornelas, IM; Pamplona, FA; Paulsen, B; Rehen, SK; Ribeiro, FC; Sudo, FK; Tovar-Moll, F; Vanderborght, B; Vitória, G1
Assunção, N; De Felice, FG; Drummond, C; Ferreira, DDP; Ferreira, ST; Gonçalves, RA; Lourenco, MV; Mattos, P; Pamplona, FA; Ribeiro, FC; Sudo, FK; Tovar-Moll, F; Vanderborght, B1
Caramelli, P; Carvalho, MDG; de Sousa, LP; de Souza, LC; Ferreira, CN; Fraga, VG; Gomes, KB; Guimarães, HC; Loures, CMG; Magalhães, CA; Zauli, DAG1
Dias, IHK; Griffiths, HR1
Aytan, N; Benincasa, C; Carreras, I; Crabtree, L; Dedeoglu, A; Jenkins, BG; Kantarci, A; Palaska, I; Stephens, D1
Bae, JS; Baek, B; Choi, MK; Han, SH; He, X; Jin, HK; Kim, SH; Lee, JY; Park, MH; Ryu, H; Schuchman, EH; Song, IS; Takuwa, Y1
Baglietto-Vargas, D; Cheng, D; Cribbs, DH; Kitazawa, M; LaFerla, FM; Medeiros, R; Passos, GF1
Cortés-Toro, V; Eriksdotter, M; Eyjolfsdottir, H; Fitzgerald, JM; Graff, C; Granholm, AC; Hjorth, E; Nennesmo, I; Palmblad, J; Sambamurti, K; Schultzberg, M; Serhan, CN; Wang, X; Zhu, M1
Ager, RR; Baglietto-Vargas, D; Cheng, D; Cribbs, DH; Dunn, HC; Kitazawa, M; Medeiros, R1
Min, Z; Wang, A; Wu, J; Xiong, Y; Xu, J; Yan, Q; Zhang, J; Zhang, S1

Other Studies

10 other study(ies) available for lipoxin a4 and Alzheimer Disease

ArticleYear
Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans.
    Translational psychiatry, 2022, 10-10, Volume: 12, Issue:1

    Topics: Aged; Alzheimer Disease; Animals; Arachidonate 5-Lipoxygenase; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Cytokines; Endocannabinoids; Humans; Inflammation; Inflammation Mediators; Lipoxins; Mice

2022
Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023, Volume: 19, Issue:6

    Topics: Alzheimer Disease; Animals; Brain-Derived Neurotrophic Factor; Brazil; Depression; Fibronectins; Lipoxins

2023
Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
    Neuroscience, 2019, 11-21, Volume: 421

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Annexin A1; Cytokines; Diagnosis, Differential; Female; Frontotemporal Dementia; Genotype; Healthy Volunteers; Humans; Inflammation; Lipoxins; Male; Middle Aged

2019
Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2021, Volume: 81, Issue:1

    Topics: Alzheimer Disease; Animals; Brain; Humans; Inflammation; Inflammation Mediators; Lipoxins

2021
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
    Experimental neurology, 2018, Volume: 300

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hippocampus; Inflammation; Lipoxins; Mice; Mice, Transgenic

2018
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.
    Nature communications, 2018, 04-16, Volume: 9, Issue:1

    Topics: Acetyl Coenzyme A; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cyclooxygenase 2; Disease Models, Animal; Humans; Lipoxins; Male; Mice; Mice, Transgenic; Microglia; Neurons; Phagocytosis; Presenilin-1; Serine; Transgenes

2018
Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice.
    The American journal of pathology, 2013, Volume: 182, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspirin; Astrocytes; Brain; Cognition; Lipoxins; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; NF-kappa B; Phenotype; Protein Processing, Post-Translational; Synapses

2013
Resolution of inflammation is altered in Alzheimer's disease.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:1

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Docosahexaenoic Acids; Female; Hippocampus; Humans; Inflammation; Inflammation Mediators; Lipoxins; Lipoxygenase; Male; Middle Aged; Receptors, Formyl Peptide; Receptors, Lipoxin; tau Proteins

2015
Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 43, Issue:3

    Topics: Alzheimer Disease; Animals; Brain; Cognition; Disease Models, Animal; Disease Progression; Lipoxins; Mice; Mice, Transgenic; Microglia; Phosphorylation; Recognition, Psychology; Signal Transduction

2015
Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo.
    Biochemical and biophysical research communications, 2011, May-13, Volume: 408, Issue:3

    Topics: Active Transport, Cell Nucleus; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Cell Nucleus; Cerebral Cortex; Cytokines; Hippocampus; I-kappa B Proteins; Inflammation; Interleukin-1beta; Lipoxins; Male; Mice; Mice, Inbred C57BL; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2011